Counterfeit Alli: lab tests show three times the normal dose of sibutramine
26 January 2010
Nancy Faigen
The
US FDA has re-iterated its concerns about a counterfeit version of GlaxoSmithKline's Alli (orlistat), which contains varying degrees of sibutramine rather than the correct active ingredient. It has warned consumers that lab tests indicate that consumers taking the counterfeit product may be ingesting...
Please Login to read the full article.
26 January 2010
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Will PDUFA V be a 'damned if it does, damned if it doesn't' scenario for FDA?
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- GSK sells non core US and Canada consumer brands to Prestige for $660m
- US Capitol Capsule: US drug shortages worsen, putting patients increasingly at risk
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
